Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme.

Khayal IS, Polley MY, Jalbert L, Elkhaled A, Chang SM, Cha S, Butowski NA, Nelson SJ.

Neuro Oncol. 2010 Sep;12(9):908-16. doi: 10.1093/neuonc/noq049. Epub 2010 May 25.

PMID:
20501631
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.

Michaelsen SR, Christensen IJ, Grunnet K, Stockhausen MT, Broholm H, Kosteljanetz M, Poulsen HS.

BMC Cancer. 2013 Sep 3;13:402. doi: 10.1186/1471-2407-13-402.

PMID:
24004722
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.

Jastaniyah N, Murtha A, Pervez N, Le D, Roa W, Patel S, Mackenzie M, Fulton D, Field C, Ghosh S, Fallone G, Abdulkarim B.

Radiat Oncol. 2013 Feb 20;8:38. doi: 10.1186/1748-717X-8-38.

PMID:
23425509
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma.

Park CK, Lee SH, Kim TM, Choi SH, Park SH, Heo DS, Kim IH, Jung HW.

J Neurooncol. 2013 Apr;112(2):277-83. doi: 10.1007/s11060-013-1060-3. Epub 2013 Feb 2.

PMID:
23377829
[PubMed - indexed for MEDLINE]
5.

Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma.

Kocher M, Frommolt P, Borberg SK, Rühl U, Steingräber M, Niewald M, Staar S, Stuschke M, Becker G, Fischedick AR, Herfarth K, Grauthoff H, Müller RP.

Strahlenther Onkol. 2008 Nov;184(11):572-9. doi: 10.1007/s00066-008-1897-0. Epub 2008 Nov 19.

PMID:
19016015
[PubMed - indexed for MEDLINE]
6.

Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma.

Mangla R, Singh G, Ziegelitz D, Milano MT, Korones DN, Zhong J, Ekholm SE.

Radiology. 2010 Aug;256(2):575-84. doi: 10.1148/radiol.10091440. Epub 2010 Jun 7.

PMID:
20529987
[PubMed - indexed for MEDLINE]
7.

Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.

Birol Sarica F, Tufan K, Cekinmez M, Sen O, Cem Onal H, Mertsoylu H, Topkan E, Pehlivan B, Erdogan B, Nur Altinors M.

J Neurosurg Sci. 2010 Mar;54(1):7-19.

PMID:
20436394
[PubMed - indexed for MEDLINE]
8.

A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?

Rock K, McArdle O, Forde P, Dunne M, Fitzpatrick D, O'Neill B, Faul C.

Br J Radiol. 2012 Sep;85(1017):e729-33. doi: 10.1259/bjr/83796755. Epub 2012 Jan 3.

PMID:
22215883
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution.

Gerstein J, Franz K, Steinbach JP, Seifert V, Rödel C, Weiss C.

Strahlenther Onkol. 2011 Nov;187(11):722-8. doi: 10.1007/s00066-011-2230-x. Epub 2011 Oct 28.

PMID:
22037649
[PubMed - indexed for MEDLINE]
10.

Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, Fisher J; NABTT CNS Consortium.

Clin Cancer Res. 2010 Apr 15;16(8):2443-9. doi: 10.1158/1078-0432.CCR-09-3106. Epub 2010 Apr 6.

PMID:
20371685
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide.

Topkan E, Topuk S, Oymak E, Parlak C, Pehlivan B.

Am J Clin Oncol. 2012 Jun;35(3):284-9. doi: 10.1097/COC.0b013e318210f54a.

PMID:
21399487
[PubMed - indexed for MEDLINE]
12.

Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials.

Balducci M, Fiorentino A, De Bonis P, Chiesa S, Mangiola A, Mattiucci GC, D'Agostino GR, Frascino V, Mantini G, Alitto AR, Colosimo C, Anile C, Valentini V.

Strahlenther Onkol. 2013 Nov;189(11):926-31. doi: 10.1007/s00066-013-0410-6. Epub 2013 Aug 24.

PMID:
23974823
[PubMed - indexed for MEDLINE]
13.

Chemoirradiation for glioblastoma multiforme: the national cancer institute experience.

Ho J, Ondos J, Ning H, Smith S, Kreisl T, Iwamoto F, Sul J, Kim L, McNeil K, Krauze A, Shankavaram U, Fine HA, Camphausen K.

PLoS One. 2013 Aug 5;8(8):e70745. doi: 10.1371/journal.pone.0070745. Print 2013.

PMID:
23940635
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.

Chu HH, Choi SH, Ryoo I, Kim SC, Yeom JA, Shin H, Jung SC, Lee AL, Yoon TJ, Kim TM, Lee SH, Park CK, Kim JH, Sohn CH, Park SH, Kim IH.

Radiology. 2013 Dec;269(3):831-40. doi: 10.1148/radiol.13122024. Epub 2013 Oct 28.

PMID:
23771912
[PubMed - indexed for MEDLINE]
15.

Pseudoprogression following chemoradiotherapy for glioblastoma multiforme.

Sanghera P, Perry J, Sahgal A, Symons S, Aviv R, Morrison M, Lam K, Davey P, Tsao MN.

Can J Neurol Sci. 2010 Jan;37(1):36-42.

PMID:
20169771
[PubMed - indexed for MEDLINE]
16.

Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.

Chen C, Damek D, Gaspar LE, Waziri A, Lillehei K, Kleinschmidt-DeMasters BK, Robischon M, Stuhr K, Rusthoven KE, Kavanagh BD.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1066-74. doi: 10.1016/j.ijrobp.2010.07.021. Epub 2010 Oct 6.

PMID:
20932651
[PubMed - indexed for MEDLINE]
17.

The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study.

Rapp M, Goeppert M, Felsberg J, Steiger HJ, Sabel M.

Br J Neurosurg. 2013 Aug;27(4):430-5. doi: 10.3109/02688697.2013.767317. Epub 2013 Feb 18.

PMID:
23418781
[PubMed - indexed for MEDLINE]
18.

Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme.

Roldán Urgoiti GB, Singh AD, Easaw JC.

J Neurooncol. 2012 May;108(1):173-7. doi: 10.1007/s11060-012-0826-3. Epub 2012 Mar 2.

PMID:
22382781
[PubMed - indexed for MEDLINE]
19.

Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma.

Minniti G, Lanzetta G, Scaringi C, Caporello P, Salvati M, Arcella A, De Sanctis V, Giangaspero F, Enrici RM.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):93-9. doi: 10.1016/j.ijrobp.2011.06.1992. Epub 2011 Nov 11.

PMID:
22079725
[PubMed - indexed for MEDLINE]
20.

Time trends in glioblastoma multiforme survival: the role of temozolomide.

Dubrow R, Darefsky AS, Jacobs DI, Park LS, Rose MG, Laurans MS, King JT Jr.

Neuro Oncol. 2013 Dec;15(12):1750-61. doi: 10.1093/neuonc/not122. Epub 2013 Sep 17.

PMID:
24046259
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk